TY - JOUR
T1 - New type of febrifugine analogues, bearing a quinolizidine moiety, show potent antimalarial activity against Plasmodium malaria parasite
AU - Takaya, Yoshiaki
AU - Tasaka, Hidehisa
AU - Chiba, Tomoyuki
AU - Uwai, Koji
AU - Tanitsu, Masa Aki
AU - Kim, Hye Sook
AU - Wataya, Yusuke
AU - Miura, Masatomo
AU - Takeshita, Mitsuhiro
AU - Oshima, Yoshiteru
PY - 1999/8/12
Y1 - 1999/8/12
N2 - Febrifugine (1) and isofebrifugine (2), isolated from the roots of Dichroa febrifuga Lour. (Chinese name: Chang Shah), are active principles against malaria. Adducts of 1 and 2 with acetone, Df-1 (3) and Df-2 (4), respectively, were obtained using silica gel and acetone. They showed high activity against P. falciparum malaria in vitro. Compound 3 was found to be equally effective against P. berghei in vivo as the clinically used drug chloroquine, whereas 4 showed only 1/24 of the activity of 3. Metabolism studies of these compounds revealed that compound 4 is readily metabolized in mouse liver. Accordingly, the dose of 4 must be higher than that of 3 to attain blood levels sufficient for a favorable therapeutic effect.
AB - Febrifugine (1) and isofebrifugine (2), isolated from the roots of Dichroa febrifuga Lour. (Chinese name: Chang Shah), are active principles against malaria. Adducts of 1 and 2 with acetone, Df-1 (3) and Df-2 (4), respectively, were obtained using silica gel and acetone. They showed high activity against P. falciparum malaria in vitro. Compound 3 was found to be equally effective against P. berghei in vivo as the clinically used drug chloroquine, whereas 4 showed only 1/24 of the activity of 3. Metabolism studies of these compounds revealed that compound 4 is readily metabolized in mouse liver. Accordingly, the dose of 4 must be higher than that of 3 to attain blood levels sufficient for a favorable therapeutic effect.
UR - http://www.scopus.com/inward/record.url?scp=0033549898&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033549898&partnerID=8YFLogxK
U2 - 10.1021/jm990131e
DO - 10.1021/jm990131e
M3 - Article
C2 - 10447961
AN - SCOPUS:0033549898
SN - 0022-2623
VL - 42
SP - 3163
EP - 3166
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 16
ER -